Powered by OpenAIRE graph
Found an issue? Give us feedback

Анализ функциональных результатов и оценка качества зрения пациентов после имплантации псевдоаккомодирующих интраокулярных линз Acrysof Restor Aspheric® и Acrysof Restor Toric®

Анализ функциональных результатов и оценка качества зрения пациентов после имплантации псевдоаккомодирующих интраокулярных линз Acrysof Restor Aspheric® и Acrysof Restor Toric®

Abstract

The results of phacoemulsification of a cataract with IOL Acrysof Restor Aspheric® (+3,0) and Acrysof Restor Toric® SND 1T4 in 48 patients between 2010-2013 are analyzed in the research.Monocular implantation of IOL Acrysof Restor Aspheric (+3,0) was carried out in 36 patients (36 eyes), binocular in 7 patients (14 eyes), monocular implantation of IOL Acrysof Restor Toric® SND 1 T4 in 5 patients (5 eyes). In the postoperative period the average visual acuity afar (BVDA) was about 0.92±0,06 and was estimated as perfect by 96% of patients, in close (BVNA) -0.62±0.06 and estimated as perfect by 83.3%. The patients with binocular implantation of IOL Acrysof Restor Aspheric® (+3,0) were best of all satisfied with the results of the operation. The need for additional correction (with glasses) of visual acuity in close (BVNA) was noted by 2 patients (4.2%) during 6 months of dynamic follow-up.

В работе проанализированы результаты факоэмульсификации катаракты с имплантацией интраокулярных линз (ИОЛ)Acrysof Restor Aspheric® (+3,0) и Acrysof Restor Toric® SND 1 Т4 у 48 пациентов за 2010 2013 годы.Монокулярная имплантация ИОЛ Acrysof Restor Aspheric (+3,0) была проведена у 36 пациентов (36 глаз), бинокулярная у 7 пациентов (14 глаз), ИОЛ Acrysof Restor Toric SND 1 Т4 монокулярно была имплантирована у 5 больных. В послеоперационном периоде средняя острота зрения вдаль (BVDA) составила 0,92±0,06 и в 96% случаев была оценена пациентами на «отлично», вблизи (BVNA) 0,62±0,06 и в 83,3% оценена на «отлично». Удовлетворенность результатами операции выразили пациенты с бинокулярной имплантацией ИОЛ Acrysof Restor Aspheric® (+3,0). Необходимость в дополнительной очковой коррекции для работы вблизи через 6 месяцев динамического наблюдения отмечена у 2 (4,2%) больных.

Keywords

ПСЕВДОАККОМОДИРУЮЩИЕ ИОЛ, ФАКОЭМУЛЬСИФИКАЦИЯ КАТАРАКТЫ, КАЧЕСТВО ЗРЕНИЯ

  • BIP!
    Impact byBIP!
    selected citations
    These citations are derived from selected sources.
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    0
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Average
Powered by OpenAIRE graph
Found an issue? Give us feedback
selected citations
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
0
Average
Average
Average